Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A
New England Journal of Medicine · 26.01.2023 · 388 (4) · 310-318
DOI: 10.1056/nejmoa2209226 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 26.01.2023. Verfasst von Annette von Drygalski und 15 weiteren Autor:innen. Beteiligte Einrichtung: From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy H…. Hauptthemen laut MEDLINE: Hemophilia A, Hemorrhage, Factor VIII, Coagulants. Die Arbeit wurde bisher 223-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Sanofi, Swedish Orphan Biovitrum.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.);…
ORCID-Profile: Angela C Weyand
Förderung
- Sanofi
- Swedish Orphan Biovitrum
Zitieren
APA
von Drygalski, A., Chowdary, P., Kulkarni, R., Susen, S., Konkle, B. A., Oldenburg, J., Matino, D., Klamroth, R., Weyand, A. C., Jimenez-Yuste, V., Nogami, K., Poloskey, S., Winding, B., Willemze, A., Knobe, K., & XTEND-1 Trial Group (2023). Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A. New England Journal of Medicine, 388(4), 310-318. https://doi.org/10.1056/nejmoa2209226
Vancouver
von Drygalski A, Chowdary P, Kulkarni R, Susen S, Konkle BA, Oldenburg J, et al. Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A. New England Journal of Medicine. 2023;388(4):310-318. doi:10.1056/nejmoa2209226
BibTeX
@article{vonDrygalski2023,
author = {von Drygalski, Annette and Chowdary, Pratima and Kulkarni, Roshni and Susen, Sophie and Konkle, Barbara A and Oldenburg, Johannes and Matino, Davide and Klamroth, Robert and Weyand, Angela C and Jimenez-Yuste, Victor and Nogami, Keiji and Poloskey, Stacey and Winding, Bent and Willemze, Annemieke and Knobe, Karin and XTEND-1 Trial Group, XTEND-1 Trial Group},
title = {Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A},
journal = {New England Journal of Medicine},
year = {2023},
volume = {388},
number = {4},
pages = {310--318},
doi = {10.1056/nejmoa2209226}
}
EUVIMED